Method for preparing cholestenone by using eutectic mixture as solubilization promoting agent through resting cell transformation
A technology of resting cell transformation and eutectic matter, applied in fermentation and other directions, can solve the problems of difficult contact between steroids and biological enzymes, affecting the speed and yield of steroid transformation reactions, low solubility, etc. It is of great significance to achieve industrialization , Mild operating conditions, the effect of improving the dispersion rate
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Example Embodiment
[0041] Example 1:
[0042] A method for preparing cholestenone by transforming resting cells using eutectic as a solvent. In this example, the catalytic conversion effects of different types of DES are tested by changing the mixing ratio of DES, as follows:
[0043] ⑴ Scrape a loop of simple Arthrobacter into sterile water, shake and mix, and add it to a 50ml / 250ml shake flask at a concentration of 0.440 for the reaction. The fermentation time of the strain is 18-22h, the temperature is 30℃, and the rotating speed of the shaker is 160rpm.
[0044] ⑵After culturing the bacteria, collect the bacteria by centrifugation, and resuspend the bacteria with 20ml phosphate buffer to make the concentration 0.4g DW / mL. Put 5‰ of the substrate cholesterol into the conversion solution, and add the eutectic to carry out the microbial conversion reaction. The added eutectic is choline chloride / ethylene glycol mixed with a molar ratio of 1:2, 1:1 , 2:1, or choline chloride / glycerin mixed molar rat...
Example Embodiment
[0049] Example 2:
[0050] A method for preparing cholestenone by transforming resting cells using eutectic as a solvent. In this example, the catalytic conversion effect of different concentrations of DES is tested by changing the percentage of DES, as follows:
[0051] ⑴ Scrape a loop of simple Arthrobacter into sterile water, shake and mix, and add it to a 50ml / 250ml shake flask at a concentration of 0.440 for the reaction. The fermentation time of the strain is 18-22h, the temperature is 30℃, and the rotating speed of the shaker is 160rpm.
[0052] ⑵After culturing the bacteria, collect the bacteria by centrifugation to make the concentration of 0.4g DW / mL Use 20ml phosphate buffer to resuspend the bacteria. Put 5‰ of the substrate cholesterol into the conversion solution, and add the eutectic choline chloride / urea (molar ratio 1:1) for conversion. The eutectic solvent accounts for 100% of the DES / phosphate buffer system. The sub-contents are 0%, 2%, 4%, 6%, 8%. The conversio...
Example Embodiment
[0054] Example 3:
[0055] A method for preparing cholestenone by using a eutectic as a solvent to transform resting cells. In this embodiment, the substrate concentration is changed to detect the catalytic conversion effect of the substrate concentration change, as follows:
[0056] ⑴ Scrape a loop of simple Arthrobacter into sterile water, shake and mix, and add it to a 50ml / 250ml shake flask at a concentration of 0.440 for the reaction. The fermentation time of the strain is 18-22h, the temperature is 30℃, and the rotating speed of the shaker is 160rpm.
[0057] ⑵After culturing the bacteria, collect the bacteria by centrifugation, and resuspend the bacteria with 20ml phosphate buffer to make the concentration 0.4g DW / mL. Put the substrate cholesterol into the conversion solution, where the substrate addition amount is 1‰, 5‰, 1%, 2%, 3%, and 2% choline chloride / urea (molar ratio 1:1) is added. The eutectic undergoes microbial transformation reactions. The conversion time is 4...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap